A leader in the success game: Deciphera Pharmaceuticals Inc (DCPH) Stock

JP Morgan raised the price target for the Deciphera Pharmaceuticals Inc (NASDAQ:DCPH) stock to “a Neutral”. The rating was released on November 20, 2023, according to finviz. The research report from Stifel has upgraded the stock from Hold to Buy, with a price target set at $20. The stock was upgraded by Guggenheim, who disclosed […]

The latest Deciphera Pharmaceuticals Inc (DCPH) Stock Technical Bulletin

JP Morgan raised the price target for the Deciphera Pharmaceuticals Inc (NASDAQ:DCPH) stock to “a Neutral”. The rating was released on November 20, 2023, according to finviz. The research report from Stifel has upgraded the stock from Hold to Buy, with a price target set at $20. The stock was upgraded by Guggenheim, who disclosed […]

Why Deciphera Pharmaceuticals Inc (NASDAQ:DCPH) Stock Decreased -6.93 percent in recent Trade?

JP Morgan raised the price target for the Deciphera Pharmaceuticals Inc (NASDAQ:DCPH) stock to “a Neutral”. The rating was released on November 20, 2023, according to finviz. Historical Earnings Surprises and Revenue Forecasts Profit is the most critical financial performance measure. Every investor in a business is looking forward to the earnings report as stock […]